Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
24,263,394
-
Share change
-
+422,146
-
Total reported value
-
$5,262,704,969
-
Put/Call ratio
-
144%
-
Price per share
-
$216.90
-
Number of holders
-
286
-
Value change
-
+$653,318,695
-
Number of buys
-
146
-
Number of sells
-
169
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q1 2021
As of 31 Mar 2021,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
286 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,263,394 shares.
The largest 10 holders included
Pentwater Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., HBK INVESTMENTS L P, Farallon Capital Management, L.L.C., GLAZER CAPITAL, LLC, ETF MANAGERS GROUP, LLC, ALPINE ASSOCIATES MANAGEMENT INC., UBS OCONNOR LLC, MILLENNIUM MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
286
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.